| type 1 diabetes |
phenotype |
24 |
6 |
T1D, type 1 diabetes, type- I diabetes |
| type 2 diabetes |
phenotype |
56 |
32 |
NIDDM, T2D, T2DM, diabetes, non-insulin-dependent diabetes, type 2 diabetes, type 2 diabetes mellitus, type II diabetes |
| typical development |
phenotype |
2 |
2 |
|
| tyrosine |
drug |
2 |
1 |
Tyr |
| UBE3A |
gene |
2 |
2 |
Ube3a |
| UCSC Genome Browser |
drug |
3 |
1 |
|
| UCSF Family Alcoholism Study |
cohort |
2 |
1 |
|
| UHS |
cohort |
2 |
2 |
UHS cases |
| UK10K |
cohort |
4 |
3 |
UK10K, UK10K reference panel |
| UKB |
cohort |
13 |
15 |
AUDIT-P, UK Biobank, UKB cohort |
| UKBB |
cohort |
5 |
1 |
UK Biobank |
| UKB cohort |
cohort |
2 |
1 |
UK Biobank |
| UK Biobank |
cohort |
46 |
28 |
British-ancestry UK Biobank, UK Biobank British samples, UK Biobank reference samples, UK Biobank samples, UK Biobank target samples, UK Biobank34, UKB, UKB GWAS summary statistics, UKB dataset, UKB individuals, UKB sample, UKB team, UKBB, non-British European ancestry UK Biobank |
| UK Biobank Axiom Array |
drug |
3 |
2 |
UK Biobank Axiom® Array |
| ulcerative colitis |
phenotype |
10 |
4 |
UC |
| unaffected |
phenotype |
5 |
— |
Control, Unaffected group |
| unaffected group |
cohort |
2 |
1 |
control participants, participants without AUD |
| unaffected individuals |
cohort |
2 |
— |
unaffected cohort |
| uncertainty |
phenotype |
2 |
2 |
|
| underage drinking |
phenotype |
6 |
3 |
underage drinkers |
